Cryptosporidium p30, a galactose/N-acetylgalactosamine-specific lectin, mediates infection in vitro.
about
Cryptosporidium pathogenicity and virulenceRelease of luminal exosomes contributes to TLR4-mediated epithelial antimicrobial defense.Galactose Recognition by the Apicomplexan Parasite Toxoplasma gondiiTegument Glycoproteins and Cathepsins of Newly Excysted Juvenile Fasciola hepatica Carry Mannosidic and Paucimannosidic N-glycansEvidence for mucin-like glycoproteins that tether sporozoites of Cryptosporidium parvum to the inner surface of the oocyst wallDiversity of extracellular proteins during the transition from the 'proto-apicomplexan' alveolates to the apicomplexan obligate parasites.Pathogenesis of acanthamoeba keratitis.The cell biology of cryptosporidium infectionHeparin interacts with elongation factor 1α of Cryptosporidium parvum and inhibits invasion.SHP-2 Mediates Cryptosporidium parvum Infectivity in Human Intestinal Epithelial Cells.Glycoproteins and Gal-GalNAc cause Cryptosporidium to switch from an invasive sporozoite to a replicative trophozoiteDifferential Gene Expression and Protein Localization of Cryptosporidium parvum Fatty Acyl-CoA Synthetase Isoforms.Roles of galectins in infectionIdentification of a family of four UDP-polypeptide N-acetylgalactosaminyl transferases in Cryptosporidium species.The Tn antigen-structural simplicity and biological complexity.Dysfunctions at human intestinal barrier by water-borne protozoan parasites: lessons from cultured human fully differentiated colon cancer cell lines.Apicomplexan infections in the gut.Glycan microarray analysis of Candida glabrata adhesin ligand specificity.Cryptosporidium parvum vaccine candidates are incompletely modified with O-linked-N-acetylgalactosamine or contain N-terminal N-myristate and S-palmitateMonoclonal Antibodies to Intracellular Stages of Cryptosporidium parvum Define Life Cycle Progression In Vitro.
P2860
Q26823336-47DC7E02-6A57-4C12-9675-E0FCF61B3594Q27335435-0A224FD6-ACDE-4ECE-B963-F668AB750D27Q27677936-095E1AC6-29F5-4464-83C6-6C90080FF48EQ28551767-53E054D5-4222-461F-A8E6-807B66103E62Q33585919-483B5A91-1D7D-4DDA-8A0A-7137CA26E090Q34502254-401BE871-5AAF-4C96-9EE6-37B62006619CQ34768834-754B9B39-9726-4488-8CA2-DA7FD5A39FCEQ35089632-1F3ABA15-BFC1-43AA-A148-745F145EB46EQ35803331-4A188407-FEDE-4870-843C-A9874D52BA43Q35837774-07F3B255-00DD-43DF-B22F-9C56CD0091C5Q36447701-39133F76-57D9-4FF1-9DC8-6F5AE6F3B753Q36642424-7122BCA2-D705-4481-B28B-A7628B5137EEQ37137327-F68327CE-0DE2-42E9-BBA1-646F968F7CA8Q37376683-400EF28C-E66A-4388-9411-1B5E177324E8Q37831859-C54DB228-420B-446F-BD58-5AF29574D29AQ38084328-C7D66930-AC75-4C1A-B905-4D1D3D67363BQ38247207-6154805E-9E9B-4E43-BF0A-8676362E62ABQ39994455-2EEF7559-BC3D-4BA4-9BC9-8988BF6D200AQ41323286-87184FCD-AFC1-4D95-BE6C-218CEC4C6CA1Q55432524-D3CB84B0-0F1B-4EDA-833C-82DB7D801652
P2860
Cryptosporidium p30, a galactose/N-acetylgalactosamine-specific lectin, mediates infection in vitro.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cryptosporidium p30, a galacto ...... , mediates infection in vitro.
@en
Cryptosporidium p30, a galacto ...... , mediates infection in vitro.
@nl
type
label
Cryptosporidium p30, a galacto ...... , mediates infection in vitro.
@en
Cryptosporidium p30, a galacto ...... , mediates infection in vitro.
@nl
prefLabel
Cryptosporidium p30, a galacto ...... , mediates infection in vitro.
@en
Cryptosporidium p30, a galacto ...... , mediates infection in vitro.
@nl
P2093
P2860
P356
P1476
Cryptosporidium p30, a galacto ...... , mediates infection in vitro.
@en
P2093
Angela Joe
Mercio PereiraPerrin
Najma Bhat
P2860
P304
34877-34887
P356
10.1074/JBC.M706950200
P407
P577
2007-09-28T00:00:00Z